DK0973501T3 - Vandig suspension til nasal indgivelse af loteprednol - Google Patents

Vandig suspension til nasal indgivelse af loteprednol

Info

Publication number
DK0973501T3
DK0973501T3 DK98900360T DK98900360T DK0973501T3 DK 0973501 T3 DK0973501 T3 DK 0973501T3 DK 98900360 T DK98900360 T DK 98900360T DK 98900360 T DK98900360 T DK 98900360T DK 0973501 T3 DK0973501 T3 DK 0973501T3
Authority
DK
Denmark
Prior art keywords
loteprednol
aqueous suspension
nasal administration
nasal
administration
Prior art date
Application number
DK98900360T
Other languages
Danish (da)
English (en)
Inventor
Koji Doi
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of DK0973501T3 publication Critical patent/DK0973501T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DK98900360T 1997-01-16 1998-01-14 Vandig suspension til nasal indgivelse af loteprednol DK0973501T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1966497 1997-01-16
PCT/JP1998/000108 WO1998031343A2 (en) 1997-01-16 1998-01-14 Aqueous suspension for nasal administration of loteprednol

Publications (1)

Publication Number Publication Date
DK0973501T3 true DK0973501T3 (da) 2004-01-19

Family

ID=12005518

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98900360T DK0973501T3 (da) 1997-01-16 1998-01-14 Vandig suspension til nasal indgivelse af loteprednol

Country Status (33)

Country Link
US (1) US6368616B1 (pl)
EP (1) EP0973501B1 (pl)
KR (1) KR100471708B1 (pl)
CN (1) CN1126535C (pl)
AR (1) AR011773A1 (pl)
AT (1) ATE249205T1 (pl)
AU (1) AU730953C (pl)
BR (1) BR9806771A (pl)
CA (1) CA2278025C (pl)
CZ (1) CZ294919B6 (pl)
DE (1) DE69818026T2 (pl)
DK (1) DK0973501T3 (pl)
EA (1) EA001775B1 (pl)
ES (1) ES2206880T3 (pl)
HK (1) HK1026138A1 (pl)
HU (1) HU226613B1 (pl)
ID (1) ID21892A (pl)
IL (1) IL130979A0 (pl)
LT (1) LT4677B (pl)
LV (1) LV12449B (pl)
MX (1) MXPA99006628A (pl)
NO (1) NO324619B1 (pl)
NZ (2) NZ509908A (pl)
PL (1) PL190753B1 (pl)
PT (1) PT973501E (pl)
RS (1) RS49701B (pl)
SI (1) SI20057A (pl)
SK (1) SK283164B6 (pl)
TR (1) TR199901663T2 (pl)
TW (1) TW503113B (pl)
UA (1) UA52722C2 (pl)
WO (1) WO1998031343A2 (pl)
ZA (1) ZA98303B (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
PT1025859E (pt) * 1998-08-26 2006-10-31 Teijin Ltd Formulacoes em po para administracao por via nasal
DE19947235A1 (de) * 1999-09-30 2001-04-05 Asta Medica Ag Neue Kombination von Loteprednol und beta¶2¶-Adrenorezeptor-Agonisten
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
US6565832B1 (en) * 2000-01-31 2003-05-20 Schering-Plough Healthcare Products, Inc. Spray composition with reduced dripping
WO2002102390A1 (en) * 2001-06-18 2002-12-27 Noven Pharmaceuticals, Inc. Enhanced drug delivery in transdermal systems
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US7811606B2 (en) * 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US9808471B2 (en) * 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) * 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
ES2339351T3 (es) 2003-06-19 2010-05-19 Nicholas S. Bodor Mejora de la actividad y/o duracion de la accion de esteroides anti-inflamatorios blandos para la aplicacion topica u otra local.
WO2004112800A1 (en) * 2003-06-19 2004-12-29 Bodor Nicholas S Enhancement of activity and/or duration of action of selected anti-inflammatory steroids
US20050095205A1 (en) * 2003-10-31 2005-05-05 Ramesh Krishnamoorthy Combination of loteprednol etabonate and tobramycin for topical ophthalmic use
AU2005229006B9 (en) 2004-03-25 2011-05-19 Bausch & Lomb Incorporated Use of loteprednol etabonate for the treatment of dry eye
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
WO2007058935A2 (en) * 2005-11-14 2007-05-24 Bausch & Lomb Incorporated Ophthalmic composition for dry eye therapy
US7691811B2 (en) * 2006-05-25 2010-04-06 Bodor Nicholas S Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
US7687484B2 (en) * 2006-05-25 2010-03-30 Bodor Nicholas S Transporter enhanced corticosteroid activity
WO2012119261A1 (en) * 2011-03-10 2012-09-13 Biocia Inc. Enhanced artificial mucus composition comprising hyaluronan for the treatment of rhinitis
AU2012312816A1 (en) 2011-09-22 2014-04-24 Bausch & Lomb Incorporated Ophthalmic gel compositions
PL3474820T3 (pl) 2017-08-24 2024-05-13 Novo Nordisk A/S Kompozycje glp-1 i ich zastosowania
EP4106724A1 (en) 2020-02-18 2022-12-28 Novo Nordisk A/S Glp-1 compositions and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5540930A (en) * 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
EP0709099A3 (en) 1994-09-28 1996-07-24 Senju Pharma Co Aqueous suspension for nasal administration containing cyclodextrin
KR100508227B1 (ko) 1997-03-14 2006-03-23 센주 세이야꾸 가부시키가이샤 로테프레드놀에타보네이트수성현탁액

Also Published As

Publication number Publication date
RS49701B (sr) 2007-12-31
AU730953B2 (en) 2001-03-22
EA199900659A1 (ru) 2000-02-28
SI20057A (sl) 2000-04-30
DE69818026T2 (de) 2004-07-08
SK94899A3 (en) 2000-05-16
SK283164B6 (sk) 2003-03-04
KR100471708B1 (ko) 2005-03-07
CZ294919B6 (cs) 2005-04-13
BR9806771A (pt) 2000-05-16
NO324619B1 (no) 2007-11-26
DE69818026D1 (de) 2003-10-16
HU226613B1 (en) 2009-04-28
AU5495298A (en) 1998-08-07
LV12449A (lv) 2000-04-20
LT99100A (en) 2000-02-25
PT973501E (pt) 2004-02-27
CZ237499A3 (cs) 2000-01-12
TW503113B (en) 2002-09-21
YU36199A (sh) 2002-09-19
AR011773A1 (es) 2000-09-13
EP0973501A2 (en) 2000-01-26
KR20000070214A (ko) 2000-11-25
MXPA99006628A (es) 2005-01-10
NZ336990A (en) 2001-03-30
ES2206880T3 (es) 2004-05-16
WO1998031343A2 (en) 1998-07-23
NO993453L (no) 1999-07-13
HUP0002473A2 (hu) 2000-12-28
US6368616B1 (en) 2002-04-09
IL130979A0 (en) 2001-01-28
UA52722C2 (uk) 2003-01-15
TR199901663T2 (xx) 1999-09-21
CN1250370A (zh) 2000-04-12
CA2278025C (en) 2005-09-06
LT4677B (lt) 2000-07-25
ID21892A (id) 1999-08-05
PL190753B1 (pl) 2006-01-31
LV12449B (en) 2000-09-20
ZA98303B (en) 1998-07-20
AU730953C (en) 2002-02-07
EP0973501B1 (en) 2003-09-10
WO1998031343A3 (en) 1998-09-17
NZ509908A (en) 2004-12-24
ATE249205T1 (de) 2003-09-15
CN1126535C (zh) 2003-11-05
CA2278025A1 (en) 1998-07-23
HUP0002473A3 (en) 2001-01-29
EA001775B1 (ru) 2001-08-27
PL334614A1 (en) 2000-03-13
NO993453D0 (no) 1999-07-13
HK1026138A1 (en) 2000-12-08

Similar Documents

Publication Publication Date Title
DK0973501T3 (da) Vandig suspension til nasal indgivelse af loteprednol
DE69831421D1 (de) Zusammensetzungen zur nasalen verabreichung
DE69815881D1 (de) Nasaler dilatator
DE69624405D1 (de) Nasenmaske
NO20003161D0 (no) Blandinger for nasal administrasjon av kannabinoider
DE60028845T8 (de) Nasale Beatmungsmaske
DK0954282T3 (da) Fremstilling af partikler til inhalation
ID25629A (id) AMINA BISIKLIK (Pecahan dari P-961362)
DE69819387D1 (de) Kehlkopfmaske
DE69815569D1 (de) Kehlkopfmaske
FR2771012B1 (fr) Pulverisateur nasal
DK1129741T3 (da) Forstövningsindretning til inhalator
IS5245A (is) Lyfjablanda úr ómeprasól
ATE213142T1 (de) Nasaler dilatator
DE69816858D1 (de) Beatmungssystem
IT1284049B1 (it) Medicamento per somministrazione nasale
NO962103D0 (no) Nasal-applikator
DE29723959U1 (de) Nasenspray-Flüssigkeit
DE69816736D1 (de) Nasale Inhaliervorrichtung
EE200300501A (et) Ninna manustatavad imidasotriasinooni sisaldavad kompositsioonid
DE60021297D1 (de) Nasaler Dilatator
FI970331A (fi) Lääkkeen antokoostumus virustenvastaisten aineiden nenään toteutettavaa antoa varten
DK1019058T3 (da) Farmaceutisk suspension omfattende hemihydratet af nevirapin
DE29717661U1 (de) Verbindung von Kernen
DE29806921U1 (de) Nasentamponade